Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC25A24 |
| Upstream (Parents) |
|---|
| (<<) MAFF → SLC25A24 |
| (<<) S100A11 → SLC25A24 |
| (<<) STK39 → SLC25A24 |
| Downstream (Children) |
|---|
| SLC25A24 → SEMA4D (>>) |
| SLC25A24 → POLR2J4 (>>) |
| SLC25A24 → RPS14P3///RPS14 (>>) |
| SLC25A24 → PRKX (>>) |
| SLC25A24 → BRD7P3 (>>) |
| SLC25A24 → TTC9 (>>) |
| SLC25A24 → PVALB (>>) |
| SLC25A24 → TAF1A (>>) |
| SLC25A24 → S100A11P1///S100A11 (>>) |
| SLC25A24 → LUZP1 (>>) |
| SLC25A24 → FAT1 (>>) |
| SLC25A24 → PAK1 (>>) |
| SLC25A24 → FZD6 (>>) |
| SLC25A24 → CDC42EP3 (>>) |
| SLC25A24 → NUDT13 (>>) |
| SLC25A24 → AGBL2 (>>) |
| SLC25A24 → RPL36AP51///RPL36A (>>) |
| SLC25A24 → INADL (>>) |
| SLC25A24 → ZCCHC14 (>>) |
